Simultaneous Inhibition of Tumor Growth and Angiogenesis for Resistant Hepatocellular Carcinoma by Co-delivery of Sorafenib and Survivin Small Hairpin RNA-Reference-Cited by-同舟云学术

Simultaneous Inhibition of Tumor Growth and Angiogenesis for Resistant Hepatocellular Carcinoma by Co-delivery of Sorafenib and Survivin Small Hairpin RNA

Published:2014-02-13 Issue:10 Volume:11 Page:3342-3351
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Shen Jianan¹,Sun Huiping¹²,Meng Qingshuo¹,Yin Qi¹,Zhang Zhiwen¹,Yu Haijun¹,Li Yaping¹

Affiliation:

1. Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China

2. School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp4006408

Reference29 articles.

1. The characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma model

2. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

3. Sorafenib Blocks the RAF/MEK/ERK Pathway, Inhibits Tumor Angiogenesis, and Induces Tumor Cell Apoptosis in Hepatocellular Carcinoma Model PLC/PRF/5

4. Primary liver cancer: Worldwide incidence and trends

5. Angiogenesis and hepatocellular carcinoma

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA;Cell Biochemistry and Biophysics;2024-07-10

2. Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review;Biomedicine & Pharmacotherapy;2024-01

3. Development of a prognostic model for anoikis and identifies hub genes in hepatocellular carcinoma;Scientific Reports;2023-09-07

4. ZLDI-8 suppresses angiogenesis and vasculogenic mimicry in drug-resistant NSCLC in vitro and in vivo;Lung Cancer;2023-08

5. Therapeutically targeting essential metabolites to improve immunometabolism manipulation after liver transplantation for hepatocellular carcinoma;Frontiers in Immunology;2023-07-10